Nurix Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Nurix Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Nurix Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Nurix Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $7.2M | 493k | 14.70 |
| 2023-12-31 | $2.9M | 282k | 10.32 |
| 2023-09-30 | $2.9M | 364k | 7.86 |
| 2023-06-30 | $3.2M | 323k | 9.99 |
| 2023-03-31 | $4.8M | 541k | 8.88 |
| 2022-12-31 | $6.8M | 622k | 10.98 |
| 2022-06-30 | $4.2M | 332k | 12.67 |
| 2022-03-31 | $4.4M | 316k | 14.01 |
| 2021-12-31 | $8.9M | 309k | 28.95 |
| 2021-09-30 | $3.7M | 125k | 29.96 |
| 2021-03-31 | $11M | 347k | 31.09 |
| 2020-12-31 | $5.2M | 160k | 32.88 |